Antipolo City, Philippines, 18 February 2016 – Team Novo Nordisk, the world’s first all-diabetes professional cycling team, returns to the country to compete in the 2016 Le Tour de Filipinas, a route that goes from Antipolo to Legaspi from February 18 to February 21, 2016.
In 2015, Team Novo Nordisk earned its first victory in the team’s history at Le Tour de Filipinas when Scott Ambrose (NZL) soloed to the win on stage two.
Seventy-five riders in 16 teams from 11 countries are participating in this year’s four-stage race, which covers a total distance of 691 kilometers. Now on its seventh edition, Le Tour de Filipinas is the only Philippine cycling tournament duly sanctioned by Union Cycliste Internationale, Philippine Cycling Federation, and Asian Cycling Federation.
Team Novo Nordisk is a global all-diabetes sports team of cyclists, triathletes and runners, spearheaded by the world’s first all-diabetes professional cycling team. The team’s mission is to inspire, educate and empower everyone affected by diabetes. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
“Team Novo Nordisk is very excited to return to Le Tour de Filipinas. This is an iconic race for us since Scott Ambrose earned the team our first victory here last year. Scott Ambrose is returning, along with the rest of the team, and they are eager to build upon these results,” said Phil Southerland, CEO and co-founder of Team Novo Nordisk. “This is our fourth season racing as an all-diabetes team and we hope to inspire and empower more people affected by diabetes to manage their condition and pursue their dreams.”
The Team Novo Nordisk professional men’s cycling team roster for Le Tour de Filipinas 2016 includes Gerd De Keijzer (Nethelands) Scott Ambrose (New Zealand), James Glasspool (Australia), Chris Williams (Australia), and Brian Kamstra (Netherlands). Chris Williams is a 34-year-old Filipino-Australian who was diagnosed with type 1 diabetes seven years ago.